Recovery story

27 November 2020

Chief Investment Officer Bernard Swords explains that the Pfizer vaccine news was very good last week and there could be more to come short-term as other providers gives updates this week. Bernard highlights that a combination of the US election outcome and the higher probability of a viable vaccine distribution from early 2021 gives an upward bias to economic growth forecasts and thus to earnings forecasts.  

  • The Goodbody Investment team favour risk assets in this environment. The team is increasing the equity exposure of the multi-asset models, with a greater cyclical bias in those additions.  
  • The team would still be cautious about deep cyclicals as these generally need inflation (and higher interest rates for banks) and despite a potentially good recovery in 2021, we are still in a low trend growth world.

Contact Us
Warning: Nothing presented on this website constitutes investment advice as it does not take into account the investment objectives, knowledge and experience or financial situation of any person. You should not act on it in any way and are advised to obtain professional advice suitable to your own individual circumstances. The value of your investment may go down as well as up. You may lose some or all of the money you invest. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.